- 米国企業
- Akero Therapeutics, Inc.
Akero Therapeutics, Inc.AKRO
時価総額
$11.1億
PER
| 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Research and development | 37 | 65 | 82 | 85 |
| General and administrative | 9 | 15 | 19 | 30 |
| Total operating expenses | 46 | 80 | 101 | 115 |
| Loss from operations | -46 | -80 | -101 | -115 |
| Interest expense | - | - | - | 1 |
| Other income, net | 2 | 1 | 0 | 4 |
| Net loss | -44 | -79 | -101 | -112 |
| Marketable Securities, Unrealized Gain (Loss) | -0 | 0 | -0 | 0 |
| Comprehensive loss | -44 | -79 | -101 | -112 |
| Net loss per share, basic | - | - | - | -2.87 |
| Net loss per share, diluted | - | - | -2.89 | -2.87 |